CGHS Rate Revision to Boost Private Hospital Earnings

The government’s revision of CGHS rates for over 2,000 medical procedures will significantly benefit private and super-specialty hospitals, especially in tier-1 cities. Reimbursement hikes of up to 22x in key specialties could raise ARPOBs by 2.5–3.5% and EBITDA by 11–22%.

Max, Apollo, Fortis, KIMS, and Medanta are key beneficiaries.